These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 18297396)

  • 1. Predicting features of breast cancer with gene expression patterns.
    Lu X; Lu X; Wang ZC; Iglehart JD; Zhang X; Richardson AL
    Breast Cancer Res Treat; 2008 Mar; 108(2):191-201. PubMed ID: 18297396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of subtypes in human epidermal growth factor receptor 2--positive breast cancer reveals a gene signature prognostic of outcome.
    Staaf J; Ringnér M; Vallon-Christersson J; Jönsson G; Bendahl PO; Holm K; Arason A; Gunnarsson H; Hegardt C; Agnarsson BA; Luts L; Grabau D; Fernö M; Malmström PO; Johannsson OT; Loman N; Barkardottir RB; Borg A
    J Clin Oncol; 2010 Apr; 28(11):1813-20. PubMed ID: 20231686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presenting features of breast cancer differ by molecular subtype.
    Wiechmann L; Sampson M; Stempel M; Jacks LM; Patil SM; King T; Morrow M
    Ann Surg Oncol; 2009 Oct; 16(10):2705-10. PubMed ID: 19593632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of axillary lymph node status of breast cancer patients by tumorbiological factors of the primary tumor.
    Fehm T; Maul H; Gebauer S; Scharf A; Baier P; Sohn C; Jäger W; Gebauer G
    Strahlenther Onkol; 2005 Sep; 181(9):580-6. PubMed ID: 16170485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in projecting clustering results across gene expression-profiling datasets.
    Lusa L; McShane LM; Reid JF; De Cecco L; Ambrogi F; Biganzoli E; Gariboldi M; Pierotti MA
    J Natl Cancer Inst; 2007 Nov; 99(22):1715-23. PubMed ID: 18000217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.
    Ross JS
    Adv Anat Pathol; 2009 Jul; 16(4):204-15. PubMed ID: 19546609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER2 expression and efficacy of preoperative paclitaxel/FAC chemotherapy in breast cancer.
    Andre F; Mazouni C; Liedtke C; Kau SW; Frye D; Green M; Gonzalez-Angulo AM; Symmans WF; Hortobagyi GN; Pusztai L
    Breast Cancer Res Treat; 2008 Mar; 108(2):183-90. PubMed ID: 17468948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single-gene biomarker identifies breast cancers associated with immature cell type and short duration of prior breastfeeding.
    Symmans WF; Fiterman DJ; Anderson SK; Ayers M; Rouzier R; Dunmire V; Stec J; Valero V; Sneige N; Albarracin C; Wu Y; Ross JS; Wagner P; Theriault RL; Arun B; Kuerer H; Hess KR; Zhang W; Hortobagyi GN; Pusztai L
    Endocr Relat Cancer; 2005 Dec; 12(4):1059-69. PubMed ID: 16322343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value.
    Voduc D; Cheang M; Nielsen T
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):365-73. PubMed ID: 18268121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laser microdissection and microarray analysis of breast tumors reveal ER-alpha related genes and pathways.
    Yang F; Foekens JA; Yu J; Sieuwerts AM; Timmermans M; Klijn JG; Atkins D; Wang Y; Jiang Y
    Oncogene; 2006 Mar; 25(9):1413-9. PubMed ID: 16261164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based molecular prognosis of breast cancer by transcriptional profiling.
    Ma Y; Qian Y; Wei L; Abraham J; Shi X; Castranova V; Harner EJ; Flynn DC; Guo L
    Clin Cancer Res; 2007 Apr; 13(7):2014-22. PubMed ID: 17404081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixture classification model based on clinical markers for breast cancer prognosis.
    Zeng T; Liu J
    Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
    Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
    J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-Dimensional microarray analysis of estrogen signal-related genes in breast cancer tissues.
    Matsumoto M; Sakamoto H; Yamaguchi Y; Seino Y; Takei H; Kurosumi M; Sasano H; Yaegashi N; Hayashi S
    Anticancer Res; 2009 Oct; 29(10):3971-5. PubMed ID: 19846938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns.
    Gruvberger S; Ringnér M; Chen Y; Panavally S; Saal LH; Borg A ; Fernö M; Peterson C; Meltzer PS
    Cancer Res; 2001 Aug; 61(16):5979-84. PubMed ID: 11507038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor-prognosis estrogen receptor-positive breast cancer identified by histopathologic subclassification.
    Webster LR; Lee SF; Ringland C; Morey AL; Hanby AM; Morgan G; Byth K; Mote PA; Provan PJ; Ellis IO; Green AR; Lamoury G; Ravdin P; Clarke CL; Ward RL; Balleine RL; Hawkins NJ
    Clin Cancer Res; 2008 Oct; 14(20):6625-33. PubMed ID: 18927304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.
    Györffy B; Lanczky A; Eklund AC; Denkert C; Budczies J; Li Q; Szallasi Z
    Breast Cancer Res Treat; 2010 Oct; 123(3):725-31. PubMed ID: 20020197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linking gene expression patterns to therapeutic groups in breast cancer.
    Martin KJ; Kritzman BM; Price LM; Koh B; Kwan CP; Zhang X; Mackay A; O'Hare MJ; Kaelin CM; Mutter GL; Pardee AB; Sager R
    Cancer Res; 2000 Apr; 60(8):2232-8. PubMed ID: 10786689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic profiling of primary breast cancer predicts axillary lymph node metastasis.
    Nakagawa T; Huang SK; Martinez SR; Tran AN; Elashoff D; Ye X; Turner RR; Giuliano AE; Hoon DS
    Cancer Res; 2006 Dec; 66(24):11825-30. PubMed ID: 17178879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.